PE20010045A1 - Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidin-2,4-diona - Google Patents

Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidin-2,4-diona

Info

Publication number
PE20010045A1
PE20010045A1 PE2000000363A PE0003632000A PE20010045A1 PE 20010045 A1 PE20010045 A1 PE 20010045A1 PE 2000000363 A PE2000000363 A PE 2000000363A PE 0003632000 A PE0003632000 A PE 0003632000A PE 20010045 A1 PE20010045 A1 PE 20010045A1
Authority
PE
Peru
Prior art keywords
diona
pyridyl
ethoxy
benzyl
amino
Prior art date
Application number
PE2000000363A
Other languages
English (en)
Inventor
Robert Gordon Giles
Stephen Moore
Michael John Sasse
Paul David James Blackler
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909471.6A external-priority patent/GB9909471D0/en
Priority claimed from GBGB9912195.6A external-priority patent/GB9912195D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of PE20010045A1 publication Critical patent/PE20010045A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

SE REFIERE A UN POLIMORFO DE LA SAL DEL ACIDO MALEICO DE 5-[4-[2-(N-METIL-N-(2-PIRIDIL)AMINO)ETOXI]BENCIL]-TIAZOLIDIN-2,4-DIONA, QUE SE CARACTERIZA POR EL ESPECTRO INFRARROJO, ESPECTRO RAMAN, ESPECTRO DE RESONANCIA MAGNETICA NUCLEAR, DIFRACCION DE RAYOS X, POR UNA DISOLUCION DEL COMPUESTO EN ETANOL DESNATURALIZADO A ALTA TEMPERATURA, QUE AL ENFRIARSE PRODUCE LA CRISTALIZACION DEL POLIMORFO; SE PUEDE PRESENTAR EN FORMA AISLADA, EN FORMA PURA, EN FORMA CRISTALINA. EL COMPUESTO PUEDE SER UTIL PARA EL TRATAMIENTO DE LA DIABETES MELLITUS Y TRASTORNOS ASOCIADOS
PE2000000363A 1999-04-23 2000-04-19 Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidin-2,4-diona PE20010045A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9909471.6A GB9909471D0 (en) 1999-04-23 1999-04-23 Novel compounds
GBGB9912195.6A GB9912195D0 (en) 1999-05-25 1999-05-25 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
PE20010045A1 true PE20010045A1 (es) 2001-03-10

Family

ID=26315459

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000363A PE20010045A1 (es) 1999-04-23 2000-04-19 Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidin-2,4-diona

Country Status (36)

Country Link
EP (2) EP1175418A2 (es)
JP (1) JP2002543076A (es)
KR (1) KR100744361B1 (es)
CN (1) CN1152878C (es)
AP (1) AP1607A (es)
AR (2) AR023560A1 (es)
AU (2) AU4307200A (es)
BG (1) BG65517B1 (es)
BR (1) BR0009935A (es)
CA (1) CA2370262A1 (es)
CO (1) CO5170419A1 (es)
CZ (1) CZ20013801A3 (es)
DZ (1) DZ3164A1 (es)
EA (1) EA003031B1 (es)
EG (1) EG23937A (es)
GC (1) GC0000250A (es)
HK (1) HK1045152A1 (es)
HR (1) HRP20010774A2 (es)
HU (1) HUP0200937A3 (es)
IL (1) IL146115A0 (es)
MA (1) MA26786A1 (es)
MX (1) MXPA01010822A (es)
MY (1) MY138673A (es)
NO (1) NO320587B1 (es)
NZ (1) NZ515167A (es)
OA (1) OA11873A (es)
PE (1) PE20010045A1 (es)
PL (1) PL351685A1 (es)
SK (1) SK14932001A3 (es)
TR (1) TR200103060T2 (es)
TW (1) TWI288749B (es)
UA (1) UA67845C2 (es)
UY (1) UY26119A1 (es)
WO (1) WO2000064893A2 (es)
YU (1) YU75401A (es)
ZA (1) ZA200108718B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020137940A1 (en) 1997-12-16 2002-09-26 Smithkline Beecham P.L.C. 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
EP1690940A1 (en) * 1999-04-13 2006-08-16 The Government of the United States of America as Represented by The Department of Health and Human Services Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences
PL351684A1 (en) 1999-04-23 2003-06-02 Smithkline Beecham Plc Polymorph of 5−[4−[2− (n−methyl−n−( 2−pyridyl)amino) ethoxy]benzyl] thiazolidine−2,4−dione, maleic acid salt
BR0009934A (pt) 1999-04-23 2002-06-04 Smithkline Beecham Plc Produto farmacêutico
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
US7241895B2 (en) * 2000-09-26 2007-07-10 Dr. Reddy's Laboratories Limited Polymorphic forms of 5-[4-[2-[n-methyl-n-(2-pyridyl)amino[ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
WO2004062667A1 (en) * 2003-01-08 2004-07-29 Dr. Reddy's Laboratories Limited Amorphous form of rosiglitazone maleate and process for preparation thereof
GB0307259D0 (en) * 2003-03-28 2003-05-07 Glaxo Group Ltd Process
EP1468997A3 (en) * 2003-04-18 2004-11-03 CHEMI S.p.A. Polymorphous forms of rosiglitazone maleate
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
TW201336497A (zh) * 2007-02-08 2013-09-16 Daiichi Sankyo Co Ltd 噻唑啶二酮化合物之結晶型及其製法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
OA11873A (en) 2006-03-27
EG23937A (en) 2008-01-14
HUP0200937A2 (en) 2002-08-28
YU75401A (sh) 2004-09-03
KR100744361B1 (ko) 2007-07-30
AU2755102A (en) 2002-05-16
MXPA01010822A (es) 2002-06-04
EA003031B1 (ru) 2002-12-26
CA2370262A1 (en) 2000-11-02
IL146115A0 (en) 2002-07-25
HRP20010774A2 (en) 2002-10-31
BG106122A (en) 2002-05-31
AP2001002329A0 (en) 2001-12-31
EP1277753A1 (en) 2003-01-22
HK1045152A1 (zh) 2002-11-15
JP2002543076A (ja) 2002-12-17
CO5170419A1 (es) 2002-06-27
MY138673A (en) 2009-07-31
TR200103060T2 (tr) 2002-05-21
AU4307200A (en) 2000-11-10
BR0009935A (pt) 2002-04-16
TWI288749B (en) 2007-10-21
KR20010110804A (ko) 2001-12-13
WO2000064893A2 (en) 2000-11-02
CN1152878C (zh) 2004-06-09
MA26786A1 (fr) 2004-12-20
SK14932001A3 (sk) 2002-02-05
CN1355800A (zh) 2002-06-26
DZ3164A1 (fr) 2000-11-02
NO320587B1 (no) 2005-12-27
EP1175418A2 (en) 2002-01-30
WO2000064893A3 (en) 2001-01-25
HUP0200937A3 (en) 2004-03-29
NZ515167A (en) 2004-02-27
UY26119A1 (es) 2000-12-29
ZA200108718B (en) 2002-12-03
BG65517B1 (bg) 2008-10-31
AR023750A1 (es) 2002-09-04
PL351685A1 (en) 2003-06-02
NO20015148L (no) 2001-12-17
AR023560A1 (es) 2002-09-04
GC0000250A (en) 2006-11-01
NO20015148D0 (no) 2001-10-22
AP1607A (en) 2006-05-03
AU771342B2 (en) 2004-03-18
UA67845C2 (uk) 2004-07-15
CZ20013801A3 (cs) 2002-07-17
EA200101122A1 (ru) 2002-04-25

Similar Documents

Publication Publication Date Title
PE20010045A1 (es) Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidin-2,4-diona
PE20010040A1 (es) Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidina-2,4-diona
PE20010044A1 (es) Polimorfo de sal del acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]-tiazolidina-2,4-diona
JP5442434B2 (ja) 新規医薬化合物
PE20000125A1 (es) Hidrato de la sal de acido maleico de 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona
PE20000058A1 (es) Nueva forma de la sal del acido maleico 5-[4-[2-(n-metil-n-(2-piridil)amino)-etoxi]bencil]tiazolidin-2,4-diona
US20070189865A1 (en) Amino cyclopropane carboxamide derivatives as bradykinin antagonists
EA007968B1 (ru) N-замещённые производные пирролидина в качестве ингибиторов дипептидилпептидазы
JP2009507791A (ja) ナイアシン受容体アゴニスト、このような化合物を含有する組成物、および治療方法
JP2005537323A (ja) Ｎ−ビアリールメチルアミノシクロアルカンカルボキサミド誘導体
Mikhailenko Growth of large single crystals of the orthorhombic paracetamol
Zhang et al. Discovery of novel dual-action antidiabetic agents that inhibit glycogen phosphorylase and activate glucokinase
BRPI0615449A2 (pt) compostos, processo para a sua manufatura, composições farmacêuticas que os compreendem, método de tratamento e/ou prevenção de enfermidades que estão associadas com a modulação de receptores de sst do subtipo 5 e uso desses compostos
CA2524511A1 (en) Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders
CA2622960A1 (en) Niacin receptor agonists, compositions containing such compounds and methods of treatment
PE20000057A1 (es) Hidrato de la sal del acido maleico de la 5-[4-[2-(n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona
ES2369315T3 (es) Derivados de piperidina-amida.
KR20060115753A (ko) 브라디키닌 길항제 또는 역 효능제로서의 알파-하이드록시아미드
PE20010050A1 (es) Dihidrato de hidrocloruro de 5-[4-[2-n-metil-n-(2-piridil)amino)etoxi]bencil]tiazolidin-2,4-diona
AR023567A1 (es) Un procedimiento para preparar un monohidrato de hidrocloruro derivado de la tiazolidin-2,4-diona
WO2006109146A2 (en) Novel heterocyclic derivatives
JP2003128639A (ja) ベンツアミド誘導体
OA12492A (en) New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them.
Ferreira et al. Learmonth et al.
ECSP003437A (es) Nuevos compuestos

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed